Natuheal Wart Remover

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common warts, characterized by a rough, cauliflower-like appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should instruct patients to wash the affected area thoroughly. Soaking the area in warm water for approximately 5 minutes may facilitate this process. After cleansing, the area must be dried completely.

A small amount of the medication should then be applied directly to cover each wart, ensuring that it is allowed to dry. This application should be repeated twice daily as necessary, with treatment continuing for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Application on irritated or infected skin, or on areas exhibiting redness, is prohibited due to the potential for exacerbating the condition. Additionally, the product should not be used in patients with diabetes or those who have poor blood circulation, as these conditions may increase the risk of adverse effects. Furthermore, application on birthmarks, warts with hair growth, or moles is contraindicated to prevent complications associated with these skin lesions.

Warnings and Precautions

For external use only; it is imperative to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is essential to rinse thoroughly with water for at least 15 minutes. Additionally, users should take precautions to avoid inhaling vapors associated with the product.

In cases of ingestion, immediate medical assistance should be sought. It is advisable to contact a Poison Control Center without delay if the product is swallowed.

Should any discomfort persist after use, it is crucial to discontinue use of the product and consult a healthcare professional for further evaluation and guidance.

Side Effects

Patients should be aware that the product is for external use only and must avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to rinse thoroughly with water for 15 minutes. Additionally, patients should refrain from inhaling vapors associated with the product.

If discomfort persists after application, patients are advised to stop use and consult a healthcare professional. This precaution is important to ensure safety and address any potential adverse reactions that may arise during use.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Natuheal Wart Remover (salicylic acid 17% wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, healthcare providers should carefully evaluate the potential risks and benefits when considering treatment for lactating patients.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential to ensure patient safety. If significant symptoms or complications develop, appropriate medical intervention should be sought immediately.

Healthcare professionals are encouraged to report any cases of suspected overdosage to the relevant authorities to contribute to the ongoing assessment of the medication's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical help or contact a Poison Control Center if the product is swallowed.

Patients should be informed that the product should not be applied to irritated or infected skin, or to reddened areas. Additionally, it is important to caution patients against using the product on birthmarks, warts with hair growth, or moles, especially if they are diabetic or have poor blood circulation.

Healthcare providers should instruct patients to stop using the product and consult a doctor if discomfort persists after application.

For patients who are pregnant or breastfeeding, it is essential to recommend consulting a health professional before using the product to ensure safety for both the patient and the child.

Storage and Handling

The product is supplied in a tube that must be kept tightly closed when not in use to maintain its integrity. It should be stored at room temperature, away from direct light to protect its formulation. It is important to discard the product after opening if it is not used within the specified time frame, which is not detailed in the provided information.

Additional Clinical Information

The product is administered topically, with a recommended application of a small amount to cover each wart. Patients should allow the application to dry and may repeat this process twice daily as needed, for a maximum duration of 12 weeks.

Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Natuheal Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)